ghk-cu tolerance downregulation desensitization long-term use effectiveness Peptide: Clinical Evidence & Injectable Protocols The Human Tripeptide GHK‐Cu in
Description
What this protocol cannot promise No published human trial measures GLOW outcomes
Last year, Kristian Gkolomeev, a decently credentialled Greek swimmer, had swum a record time at a private Enhanced event, while wearing a supersuit, a feat for which Enhanced paid him a million dollars
Medscape Reference
Start with a low concentration (0.5-1%), apply every third day initially, and increase frequency gradually
